a year ago
ITCI
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 11%
#462 out of 4587 analysts
Average Return
+13.88%
Win Rate
57%39 out of 69
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-09 - 2024-02-23 | Strong Buy |
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-25 - 2020-06-10 | Strong Buy |
Ascendis Pharma AASND | +134.77% | $27.90 | $65.50 | 2017-05-10 - 2018-05-11 | Strong Buy |
Tricida IncTCDAQ | +80.43% | $0.55 | $0.11 | 2022-10-24 - 2023-01-23 | Strong Sell |
Nektar TherapeuticsNKTR | +79.06% | $4.87 | $1.02 | 2022-08-07 - 2023-08-07 | Strong Sell |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
a year ago
LEGN
a year ago
LEGN
2 years ago
VRTX
2 years ago
MRNA
2 years ago
IMCR
2 years ago
UTHR
2 years ago
CARA
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascendis Pharma AASND | 3 | Strong Buy | $170.00 | +40.36% | Maintains | 17 days ago |
Stoke Therapeutics IncSTOK | 2 | Hold | $13.00 | -6.47% | Maintains | 2 months ago |
Biontech SeBNTX | 5 | Strong Sell | $90.00 | -0.67% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $190.00 | +74.33% | Maintains | 2 months ago |
Deciphera Pharmaceuticals IncDCPH | 4 | Hold | $16.00 | -37.16% | Maintains | 2 months ago |
Immunocore Holdings PLCIMCR | 3 | Strong Buy | $70.00 | +31.36% | Maintains | 2 months ago |
Beigene LtdBGNE | 2 | Strong Buy | $186.00 | +7.61% | Maintains | 2 months ago |
Novocure LtdNVCR | 3 | Hold | $17.00 | -22.69% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $450.00 | +1.08% | Maintains | 3 months ago |
Ionis Pharmaceuticals IncIONS | 1 | Hold | $55.00 | +47.41% | Maintains | 4 months ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $45.00 | +6.89% | Maintains | 5 months ago |
Karuna Therapeutics IncKRTX | 1 | Hold | $330.00 | +0.05% | Downgrades | 5 months ago |
Moderna IncMRNA | 5 | Hold | $90.00 | -32.28% | Maintains | 6 months ago |
Biocryst Pharmaceuticals IncBCRX | 2 | Strong Buy | $10.00 | +59.24% | Reinstates | 6 months ago |
Mirum Pharmaceuticals IncMIRM | 2 | Strong Buy | $37.00 | +53.72% | Reinstates | 6 months ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Strong Buy | $35.00 | -31.91% | Reinstates | 6 months ago |
Denali Therapeutics IncDNLI | 2 | Strong Buy | $28.00 | +36.52% | Reinstates | 6 months ago |
Insmed IncINSM | 2 | Strong Buy | $36.00 | +45.34% | Reinstates | 6 months ago |
Alkermes PLCALKS | 3 | Hold | $33.00 | +36.65% | Reinstates | 6 months ago |
Rayzebio IncRYZB | 1 | Strong Buy | $30.00 | -51.99% | Initiates Coverage On | 7 months ago |
Intra Cellular Therapies IncITCI | 3 | Strong Buy | $62.00 | -4.62% | Maintains | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $76.00 | N/A | Maintains | a year ago |
Emergent Biosolutions IncEBS | 1 | Strong Sell | $9.00 | N/A | Downgrades | a year ago |
Esperion Therapeutics IncESPR | 5 | Hold | $9.00 | N/A | Maintains | a year ago |
Halozyme Therapeutics IncHALO | 3 | Strong Buy | $52.00 | N/A | Maintains | a year ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | N/A | Maintains | a year ago |
Incyte CorpINCY | 2 | Hold | $80.00 | N/A | Maintains | a year ago |
United Therapeutics CorpUTHR | 5 | Strong Buy | $265.00 | N/A | Maintains | 2 years ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Biomarin Pharmaceutical IncBMRN | 1 | Strong Buy | $112.00 | N/A | Maintains | 2 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | $200.00 | N/A | Maintains | 2 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Amarin Corp PLCAMRN | 1 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Cara Therapeutics IncCARA | 2 | Strong Buy | $20.00 | N/A | Upgrades | 2 years ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | 2 years ago |
Dianthus Therapeutics IncDNTH | 1 | Hold | $7.00 | N/A | Downgrades | 3 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $7.00 | N/A | Upgrades | 3 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 4 years ago |
Axcella Health IncAXLA | 2 | Strong Buy | $275.00 | N/A | Maintains | 5 years ago |
Aprea Therapeutics IncAPRE | 1 | Hold | $460.00 | N/A | Initiates Coverage On | 5 years ago |
Mersana Therapeutics IncMRSN | 4 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 6 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $52.00 | N/A | Maintains | 6 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Advanced Accelerator Applications SaAAAP | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.